Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Leantime selected for the RIoT Accelerator Program Cohort XVI

From Leantime

By Gloria Folaron

September 2, 2023

Leantime selected for the RIoT Accelerator Program Cohort XVI

Leantime selected for the RIoT Accelerator Program Cohort XVI
Leantime said it was selected as one of seven companies in the Fall XVI RIoT Accelerator Program, joining the equity-free accelerator to support sustainable business growth.

View original article on leantime.io

Most Recent

WhatsApp Business API Updates 2026: What Every Dev Needs to Know

WhatsApp Business API Updates 2026: What Every Dev Needs to Know

Everything that changed in WhatsApp Business API in 2026: new pricing tiers, AI features, regional changes, and what is coming next for developers.

May 16, 2026

Particle brings its AI-powered news reader to the web

Particle brings its AI-powered news reader to the web

Particle, the startup behind an AI-powered newsreader that aims to help publishers, not just steal their work, is bringing its product to the web. On

May 6, 2025

MuReva Phototherapy presents data from pilot study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation Device during the ASTRO 2023 Annual Meeting

MuReva Phototherapy presents data from pilot study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation Device during the ASTRO 2023 Annual Meeting

MuReva Phototherapy presented data from a pilot prospective study of the company's Intraoral Photobiomodulation Device during the ASTRO 65th Annual Meeting in San Diego

Oct 2, 2023

MuReva Phototherapy presents data from pilot study of company's photobiomodulation device during 2023 MASCC Annual Meeting

MuReva Phototherapy presents data from pilot study of company's photobiomodulation device during 2023 MASCC Annual Meeting

MuReva Phototherapy presented data from a pilot trial using the company's LED-based intraoral Photobiomodulation device for daily use in head and neck cancer patients during MASCC 2023

Jun 22, 2023

Similar Posts

Leantime Selected to Participate in the AWS Impact Accelerator Latino Founders Cohort

Leantime Selected to Participate in the AWS Impact Accelerator Latino Founders Cohort

Leantime announced it was selected for the AWS Impact Accelerator Latino Founders Cohort to accelerate its cloud-native business and AI roadmap.

May 11, 2023

Cleo Capital launches cybersecurity accelerator to help undo the ‘crushing burden’ of online threats

Cleo Capital launches cybersecurity accelerator to help undo the ‘crushing burden’ of online threats

Cleo Capital, the early-stage venture fund that counts the AI firm Groq, fintech company Ellevest, and fashion brand Hill House as investments, has announced the launch of a new cybersecurity accelerator. The program is looking for pre-seed and seed companies from all around the world. The accelerator is a remote, 12-week program, with a standard investment of $250,000 for 7% equity. Up to ten companies will be selected for the program, according to the venture fund. Sarah Kunst, the founder an

Nov 26, 2024

Leantime joins Techstars NYC 2023 Winter cohort and becomes a Techstars portfolio company

Leantime joins Techstars NYC 2023 Winter cohort and becomes a Techstars portfolio company

Leantime announced it had joined the Techstars NYC 2023 Winter cohort and become a Techstars portfolio company.

Nov 15, 2023

Leantime is a recipient of NC Idea Micro Grant

Leantime is a recipient of NC Idea Micro Grant

Leantime announced it was selected as one of fifteen companies to receive a Spring 2023 NC IDEA MICRO grant.

Apr 28, 2023

Most Recent

WhatsApp Business API Updates 2026: What Every Dev Needs to Know

WhatsApp Business API Updates 2026: What Every Dev Needs to Know

Everything that changed in WhatsApp Business API in 2026: new pricing tiers, AI features, regional changes, and what is coming next for developers.

May 16, 2026

Particle brings its AI-powered news reader to the web

Particle brings its AI-powered news reader to the web

Particle, the startup behind an AI-powered newsreader that aims to help publishers, not just steal their work, is bringing its product to the web. On

May 6, 2025

MuReva Phototherapy presents data from pilot study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation Device during the ASTRO 2023 Annual Meeting

MuReva Phototherapy presents data from pilot study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation Device during the ASTRO 2023 Annual Meeting

MuReva Phototherapy presented data from a pilot prospective study of the company's Intraoral Photobiomodulation Device during the ASTRO 65th Annual Meeting in San Diego

Oct 2, 2023

MuReva Phototherapy presents data from pilot study of company's photobiomodulation device during 2023 MASCC Annual Meeting

MuReva Phototherapy presents data from pilot study of company's photobiomodulation device during 2023 MASCC Annual Meeting

MuReva Phototherapy presented data from a pilot trial using the company's LED-based intraoral Photobiomodulation device for daily use in head and neck cancer patients during MASCC 2023

Jun 22, 2023

Similar Posts

Leantime Selected to Participate in the AWS Impact Accelerator Latino Founders Cohort

Leantime Selected to Participate in the AWS Impact Accelerator Latino Founders Cohort

Leantime announced it was selected for the AWS Impact Accelerator Latino Founders Cohort to accelerate its cloud-native business and AI roadmap.

May 11, 2023

Cleo Capital launches cybersecurity accelerator to help undo the ‘crushing burden’ of online threats

Cleo Capital launches cybersecurity accelerator to help undo the ‘crushing burden’ of online threats

Cleo Capital, the early-stage venture fund that counts the AI firm Groq, fintech company Ellevest, and fashion brand Hill House as investments, has announced the launch of a new cybersecurity accelerator. The program is looking for pre-seed and seed companies from all around the world. The accelerator is a remote, 12-week program, with a standard investment of $250,000 for 7% equity. Up to ten companies will be selected for the program, according to the venture fund. Sarah Kunst, the founder an

Nov 26, 2024

Leantime joins Techstars NYC 2023 Winter cohort and becomes a Techstars portfolio company

Leantime joins Techstars NYC 2023 Winter cohort and becomes a Techstars portfolio company

Leantime announced it had joined the Techstars NYC 2023 Winter cohort and become a Techstars portfolio company.

Nov 15, 2023

Leantime is a recipient of NC Idea Micro Grant

Leantime is a recipient of NC Idea Micro Grant

Leantime announced it was selected as one of fifteen companies to receive a Spring 2023 NC IDEA MICRO grant.

Apr 28, 2023